When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Advocates celebrate 2023 legislation capping insulin prices for people on the state employee health insurance plan in a ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Jae Oh, author of "Maximize Your Medicare," echoed this advice: "If you plan to leave Medicare Advantage and return to original Medicare, securing acceptance for a Medigap plan should be your first ...

Telehealth brand Hims & Hers donated $1 million to President-elect Donald Trump's inaugural committee, the company told Axios ...

Bernstein upgraded Novo Nordisk (NYSE:NVO) to “Market Perform” with a stock price of $84.86. The company’s stock shows slight ...

Insulin has long been the typical pharmacological go-to agent for gestational diabetes, the researchers pointed out, but oral ...

Aurora (AUR) partners with Continental and NVIDIA to deploy driverless trucks at scale by 2027, revolutionizing the ...

Social media giant Meta ( NASDAQ: META) is ending its third-party fact-checking program in the U.S. and will instead move to ...